Table 2.
Tyrosine kinase genes investigated
| Number | Gene name | Number | Gene name | Number | Gene name |
| 1 | AATK | 32 | ERBB4 | 63 | MST1R |
| 2 | ABL1 | 33 | FER | 64 | MUSK |
| 3 | ABL2 | 34 | FES | 65 | NTRK1 |
| 4 | ALK | 35 | FGFR1 | 66 | NTRK2 |
| 5 | ARAF | 36 | FGFR2 | 67 | NTRK3 |
| 6 | AXL | 37 | FGFR3 | 68 | PDGFRA |
| 7 | BLK | 38 | FGFR4 | 69 | PDGFRB |
| 8 | BMX | 39 | FGR | 70 | PTK2 |
| 9 | BRAF | 40 | FLT1 | 71 | PTK2B |
| 10 | BTK | 41 | FLT3 | 72 | PTK6 |
| 11 | CSF1R | 42 | FLT4 | 73 | PTK7 |
| 12 | CSK | 43 | FRK | 74 | RAF1 |
| 13 | DDR1 | 44 | FYN | 75 | RET |
| 14 | DDR2 | 45 | HCK | 76 | ROR1 |
| 15 | EGFR | 46 | IGF1R | 77 | ROR2 |
| 16 | EPHA1 | 47 | INSR | 78 | ROS1 |
| 17 | EPHA2 | 48 | INSRR | 79 | RYK |
| 18 | EPHA3 | 49 | ITK | 80 | SRC |
| 19 | EPHA4 | 50 | JAK1 | 81 | SRMS |
| 20 | EPHA5 | 51 | JAK2 | 82 | STYK1 |
| 21 | EPHA6 | 52 | JAK3 | 83 | SYK |
| 22 | EPHA7 | 53 | KDR | 84 | TEC |
| 23 | EPHA8 | 54 | KIT | 85 | TEK |
| 24 | EPHA10 | 55 | LCK | 86 | TIE1 |
| 25 | EPHB1 | 56 | LMTK2 | 87 | TNK1 |
| 26 | EPHB2 | 57 | LMTK3 | 88 | TNK2 |
| 27 | EPHB3 | 58 | LTK | 89 | TXK |
| 28 | EPHB4 | 59 | LYN | 90 | TYK2 |
| 29 | EPHB6 | 60 | MATK | 91 | TYRO3 |
| 30 | ERBB2 | 61 | MERTK | 92 | YES1 |
| 31 | ERBB3 | 62 | MET | 93 | ZAP70 |
AATK = apoptosis associated tyrosine kinase; ABL1 = ABL proto-oncogene 1, non-receptor tyrosine kinase; ABL2 = ABL proto-oncogene 2, non-receptor tyrosine kinase; ALK = ALK receptor tyrosine kinase; ARAF = a-raf proto-oncogene, serine/threonine kinase; AXL = AXL receptor tyrosine kinase; BLK = BLK proto-oncogene, src family tyrosine kinase; BMX = BMX non-receptor tyrosine kinase; BRAF = b-raf proto-oncogene, serine/threonine kinase; BTK = bruton tyrosine kinase; CSF1R = colony stimulating factor 1 receptor; CSK = c-terminal src kinase; DDR1 = discoidin domain receptor tyrosine kinase 1; DDR2 = discoidin domain receptor tyrosine kinase 1; EGFR = epidermal growth factor receptor; EPHA1 = erythropoietin-producing hepatoma receptor a1; EPHA2 = erythropoietin-producing hepatoma receptor a2; EPHA3 = erythropoietin-producing hepatoma receptor a3; EPHA4 = erythropoietin-producing hepatoma receptor a4; EPHA5 = erythropoietin-producing hepatoma receptor a5; EPHA6 = erythropoietin-producing hepatoma receptor a6; EPHA7 = erythropoietin-producing hepatoma receptor a7; EPHA8 = erythropoietin-producing hepatoma receptor a8; EPHA10 = erythropoietin-producing hepatoma receptor a10; EPHB1 = EPH receptor b1; EPHB2 = EPH receptor b2; EPHB3 = EPH receptor b3; EPHB4 = EPH receptor b4; EPHB6 = EPH receptor b6; ERBB2 = erb-b2 receptor tyrosine kinase 2; ERBB3 = erb-b2 receptor tyrosine kinase 3; ERBB4 = erb-b2 receptor tyrosine kinase 3; FER = proto-oncogene tyrosine-protein kinase FER; FES = FES proto-oncogene, tyrosine kinase; FGFR1 = fibroblast growth factor receptor 1; FGFR2 = fibroblast growth factor receptor 2; FGFR3 = fibroblast growth factor receptor 3; FGFR4 = fibroblast growth factor receptor 4; FGR = FGR proto-oncogene, src family tyrosine kinase; FLT1 = FMS related receptor tyrosine kinase 1; FLT3 = FMS related receptor tyrosine kinase 3; FLT4 = FMS related receptor tyrosine kinase 4; FRK = fyn related src family tyrosine kinase; FYN = FYN proto-oncogene, src family tyrosine kinase; HCK = HCK proto-oncogene, src family tyrosine kinase; IGF1R = insulinlike growth factor 1 receptor; INSR = insulin receptor; INSRR = insulin receptor related receptor; ITK = il2 inducible t cell kinase, JAK1 = janus kinase 1; JAK2 = janus kinase 2; JAK3 = janus kinase 3; KDR = kinase insert domain receptor; KIT = KIT proto-oncogene; receptor tyrosine kinase, LCK = LCK proto-oncogene, src family tyrosine kinase; LMTK2 = lemur tyrosine kinase 2; LMTK3 = lemur tyrosine kinase 3; LTK = leukocyte receptor tyrosine kinase; LYN = LYN proto-oncogene, src family tyrosine kinase; MATK = megakaryocyte-associated tyrosine kinase; MERTK = MER proto-oncogene, tyrosine kinase; MET = MET proto-oncogene, receptor tyrosine kinase; MST1R = macrophage-stimulating 1 receptor; MUSK = muscle-associated receptor tyrosine kinase; NTRK1 = neurotrophic receptor tyrosine kinase 1; NTRK2 = neurotrophic receptor tyrosine kinase 2; NTRK3 = neurotrophic receptor tyrosine kinase 3; PDGFRA = platelet-derived growth factor receptor alpha; PDGFRB = platelet-derived growth factor receptor beta; PTK2 = protein tyrosine kinase 2; PTK2B = protein tyrosine kinase 2 beta; PTK6 = protein tyrosine kinase 6; PTK7 = protein tyrosine kinase 7; RAF1 = raf-1 proto-oncogene, serine/threonine kinase; RET = ret proto-oncogene; ROR1 = receptor tyrosine kinase-like orphan receptor 1; ROR2 = receptor tyrosine kinase-like orphan receptor 2; ROS1 = ROS proto-oncogene 1, receptor tyrosine kinase; RYK = receptor-like tyrosine kinase; SRC = SRC proto-oncogene, non-receptor tyrosine kinase; SRMS = src-related kinase lacking c-terminal regulatory tyrosine and n-terminal myristylation sites; STYK1 = serine/threonine/tyrosine kinase 1; SYK = spleen-associated tyrosine kinase; TEC = tec protein tyrosine kinase; TEK = TEK receptor tyrosine kinase; TIE1 = tyrosine kinase with immunoglobulin-like and egf-like domains 1; TNK1 = tyrosine kinase non-receptor 1; TNK2 = tyrosine kinase non-receptor 2; TXK = TXK tyrosine kinase; TYK2 = tyrosine kinase 2; TYRO3 = TYRO3 protein tyrosine kinase; YES1 = YES proto-oncogene 1, src family tyrosine kinase; ZAP70 = zeta chain of t cell receptor associated protein kinase 70.